Anavex Life Sciences
AVXL
AVXL
168 hedge funds and large institutions have $316M invested in Anavex Life Sciences in 2024 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 50 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding
Funds holding: 144 → 168 (+24)
3.03% more ownership
Funds ownership: 31.8% → 34.84% (+3%)
Holders
168
Holding in Top 10
1
Calls
$15.9M
Puts
$9.78M
Top Buyers
| 1 | +$9.63M | |
| 2 | +$6.34M | |
| 3 | +$4.75M | |
| 4 |
EP
Essential Planning
Portsmouth,
New Hampshire
|
+$3.25M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.1M |
Top Sellers
| 1 | -$7.02M | |
| 2 | -$2.03M | |
| 3 | -$1.43M | |
| 4 |
Goldman Sachs
New York
|
-$1.33M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$949K |